Close Menu

Enzo

Bio-Rad Laboratories has been awarded US Patent No. 8,560,247, "Multi-stage, regression-based PCR analysis system."
Jeffrey Lerner is named as the inventor.

The California Institute of Technology of Pasadena has received US Patent No. 8,557,199, "Self-powered microfluidic devices, methods and systems." The claimed device consists of microfluidic channels and a pressure source for pumping reagents through the channels.

NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market on Tuesday a 12 percent drop in total revenues for its fiscal fourth quarter.

NEW YORK (GenomeWeb News) – A federal court has upheld a jury verdict which awarded Enzo Biochem $48.6 million after finding that Life Technologies has infringed Enzo's patents.

NEW YORK (GenomeWeb News) – Enzo Biochem has filed a shelf registration to separately offer up to $50 million of its securities and another $18 million of its common stock.

Universidad del Pais Vasco of Leioa-Vizcaya, Spain, has been awarded US Patent No. 8,486,637, "Methods and reagents for the detection of Salmonella spp."

NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market Monday that its third-quarter revenues fell 13 percent year over year as sales from its clinical lab services and products both declined.

ProFact Proteomics has introduced its PROfessor product for the enrichment of samples for functional and chemical proteomic applications.

Enzo Diagnostics has been awarded US Patent No. 8,445,664, "Kits for amplifying and detecting nucleic acid sequences."
Elazar Rabbani, Jannis Stavrianopoulos, James Donegan, Jack Coleman, and Marleen Walter are named as inventors.

NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market on Tuesday that revenues for its fiscal second quarter dropped 11 percent year over year.

Pages

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.